Table 2.

Summary of in vivo samples used to study the effect of the HDACI VPA on nuclear morphometry of prostate cancer cell lines and normal tissue

Control vs 0.2% VPAControl vs 0.4% VPA
PC31,119 (4) vs 701 (4)1,119 (4) vs 1,260 (6)
DU145NA1,975 (10) vs 2,010 (9)
LNCaPNA823 (5) vs 1,147 (6)
C4-2NA1,463 (7) vs 1,424 (7)
CWR22R1,323 (6) vs 863 (4)1,323 (6) vs 695 (3)
LiverNA940 (4) vs 1,190 (5)
KidneyNA1,522 (6) vs 1,358 (5)

NOTE: 1,119 (4) vs 701 (4) means 1,119 cells captured from 4 xenografts for control and 701 cells captured from 4 xenografts for 0.2% VPA.